Pharmacokinetic and pharmaceutical properties of a novel buprenorphine/naloxone sublingual tablet for opioid substitution therapy versus conventional buprenorphine/naloxone sublingual tablet in healthy volunteers. Jönsson M, Mundin G, Sumner M…

Primary Care and the Opioid-Overdose Crisis — Buprenorphine Myths and Realities Sarah E. Wakeman, M.D., and Michael L. Barnett, M.D. N Engl J Med 2018; 379:1-4, DOI: 10.1056/NEJMp1802741 https://www.nejm.org/doi/full/10.1056/NEJMp1802741

Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial. Lofwall MR, Walsh SL, Nunes EV, Bailey GL, Sigmon SC, Kampman KM, Fr…

Die Umstellung von y-Agonisten auf Buprenorphin Dr.med.F. Matschinski, Schwerpunktpraxis für Suchtmedizin Ravensburg Präsentation (Folien) von der DSÄ-Fortbildungsveranstaltung vom 14.04. in Köln-Sürth https://www.dsae.de…

Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14+ CD16+ monocytes. Jaureguiberry-Bravo M, Lopez L, Berman JW. J Leukoc Biol. 2018 May 23. doi: 10.1002/JLB.3HI0118-015R.  Abstract https://www.ncbi.nlm.nih.gov/pubmed…

USA. San Francisco will bring anti-addiction medication to users on the streets (...) The city announced Thursday that its medical providers will offer buprenorphine and naltrexone prescriptions at needle exchanges, in parks and in other places whe…